KRAS and adenocarcinoma: However, in lung cancer, NRF2-deficient mice treated with the lung carcinogen, urethane, were reported to initially manifest an increase in tumor formation, whereas the corresponding NRF2-sufficient, chemically treated mice developed more tumors at later stages with a higher number of K-RAS-mutated adenocarcinomas [35].